U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07142096) titled 'WinQ : a Window of Opportunity Study With MitoQ in Breast Cancer' on July 15.

Brief Summary: The purpose of the study is to validate biomarkers in blood and tumor biopsy in patients with Triple Negative Breast Cancer, after a course of MitoQ treatment

Study Start Date: July 20

Study Type: INTERVENTIONAL

Condition: Breast Cancer

Intervention: DIETARY_SUPPLEMENT: MitoQ (mitoquinol mesylate)

Dietary supplement course before surgery or chemo/radio-therapy

Recruitment Status: RECRUITING

Sponsor: Universite Catholique de Louvain

Published by HT Digital Content Services with permission from Health Daily Digest....